Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00568906 · ClinicalTrials.gov registry record
Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 129
- Enrollment target
NCT00568906: Clinical Trial study, sponsored by Stanford University.
NCT00568906 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 129 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00568906 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 129 participants
- Enrollment target
Study Summary
This study will help us understand the gene expression profiles of lung cancer. We will identify genes related to lung cancer development, their growth and metastasis to the lung. In addition, we will examine the role nicotine in the development and progression of lung tumors of smokers, ex-smokers, non-smokers on supplemental nicotine and non smokers with no exposure to nicotine.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2002-02 |
| Est. Completion | 2011-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00568906
The ClinicalTrials.gov registry entry for NCT00568906 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00568906 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00568906 about?
NCT00568906 is a clinical study titled "Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma". This study will help us understand the gene expression profiles of lung cancer. We will identify genes related to lung cancer development, their growth and metastasis to the lung. In addition, we will examine the role nicotine in the development and progression of lung tumors of smokers, ex-smokers,...
What is the current status of trial NCT00568906?
This trial is currently terminated. The enrollment target is 129 participants. The study started on 2002-02. Estimated completion is 2011-10.
Who is sponsoring clinical trial NCT00568906?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.